14-36517900-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_001079668.3(NKX2-1):c.584G>A(p.Arg195Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R195W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001079668.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NKX2-1 | NM_001079668.3 | c.584G>A | p.Arg195Gln | missense_variant | 3/3 | ENST00000354822.7 | |
SFTA3 | NR_161364.1 | n.89+1568G>A | intron_variant, non_coding_transcript_variant | ||||
NKX2-1 | NM_003317.4 | c.494G>A | p.Arg165Gln | missense_variant | 2/2 | ||
SFTA3 | NR_161365.1 | n.89+1568G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NKX2-1 | ENST00000354822.7 | c.584G>A | p.Arg195Gln | missense_variant | 3/3 | 1 | NM_001079668.3 | P4 | |
ENST00000634305.1 | n.322+69063C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome ? Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Mar 19, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg195 amino acid residue in NKX2-1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20020530, 23430038). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 505233). This missense change has been observed in individual(s) with clinical features of NKX2-1-related conditions (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 195 of the NKX2-1 protein (p.Arg195Gln). - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 20, 2016 | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg195Gln variant in NKX2-1 has not been previously reported in individuals with pulmonar y disease or in large population studies. However, a variant at the same codon ( p.Arg195Trp, c.583C>T) has been identified de novo in two individuals with featu res consistent with Brain-Lung-Thyroid syndrome (Guillot 2009, listed as p.Arg16 5Trp and Hamvas 2013). The p.Arg195Gln variant is located in the DNA binding dom ain of the NKX2-1 transcription factor and the affected amino acid is conserved in evolution, increasing the likelihood that the variant affects protein functio n. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Arg195Gln variant is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at